These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9185508)

  • 21. Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.
    van Haperen R; van Gent T; van Tol A; de Crom R
    Atherosclerosis; 2013 Mar; 227(1):37-42. PubMed ID: 23313246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
    J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
    Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
    Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Oshima R; Ikeda T; Watanabe K; Itakura H; Sugiyama N
    Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.
    Reis ED; Li J; Fayad ZA; Rong JX; Hansoty D; Aguinaldo JG; Fallon JT; Fisher EA
    J Vasc Surg; 2001 Sep; 34(3):541-7. PubMed ID: 11533609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
    Fujii A; Allen TJ; Nestel PJ
    Atherosclerosis; 2007 Jul; 193(1):55-61. PubMed ID: 16996521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.
    Rong JX; Li J; Reis ED; Choudhury RP; Dansky HM; Elmalem VI; Fallon JT; Breslow JL; Fisher EA
    Circulation; 2001 Nov; 104(20):2447-52. PubMed ID: 11705823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.
    Grimsditch DC; Penfold S; Latcham J; Vidgeon-Hart M; Groot PH; Benson GM
    Atherosclerosis; 2000 Aug; 151(2):389-97. PubMed ID: 10924715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.
    Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H; Reddick RL; Maeda N
    Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic Acid.
    Nakata Y; Maeda N
    Circulation; 2002 Mar; 105(12):1485-90. PubMed ID: 11914259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.
    Iwasa S; Fan J; Miyauchi T; Watanabe T
    Pathobiology; 2001; 69(1):1-10. PubMed ID: 11641611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice.
    Benson GM; Schiffelers R; Nicols C; Latcham J; Vidgeon-Hart M; Toseland CD; Suckling KE; Groot PH
    Atherosclerosis; 1998 Dec; 141(2):237-47. PubMed ID: 9862172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of probucol on cholesterol metabolism in mouse peritoneal macrophages: inhibition of HDL-mediated cholesterol efflux.
    Takemura T; Sakai M; Matsuda H; Matsumura T; Biwa T; Anami Y; Nishikawa T; Sasahara T; Shichiri M
    Atherosclerosis; 2000 Oct; 152(2):347-57. PubMed ID: 10998462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of probucol in two animal models of atherosclerosis.
    Lau AK; Witting PK; Chaufour X; Celermajer DS; Pettersson K; Stocker R
    Redox Rep; 2000; 5(2-3):116-8. PubMed ID: 10939287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.